Comparable with the results of studies performed in mice lacking glucagon receptors (38), both doses of NOX-G15 effectively reduced the peak of glucose increase in ipGTT in both T1DM and T2DM animal models, allowing blood glucose to decline to pre-test levels after 70 or 100 min. Here, GCGR is linked to type 2 diabetes mellitus.